Introduction {#s1}
============

In Europe, ticks are the most important vectors of human and animal infectious diseases, and transmit more pathogens than any other arthropod (Jongejan and Uilenberg, [@B22]; Colwell et al., [@B6]). These diseases are normally maintained in stable natural cycles involving ticks, wildlife, and/or domestic animals, whereas humans are accidental hosts (De La Fuente et al., [@B11]). *Ixodes ricinus* is the most widespread and abundant European tick species capable of transmitting several diseases of both medical and veterinary importance (Heyman et al., [@B18]). *Ixodes ricinus* has the greatest impact on human public health by transmitting Lyme borreliosis etiological agents, caused by at least four *Borrelia* genospecies in Europe: *Borrelia burgdorferi* sensu stricto, *Borrelia garinii*, *Borrelia afzelii*, and *Borrelia spielmanii*. The relapsing fever spirochete, *Borrelia miyamotoi*, is transmitted by the same *Ixodes* species and has recently been described in ticks as well as in a human case from the Netherlands (Hovius et al., [@B20]). In addition to *Borrelia* transmission, *Ixodes ricinus* can transmit many other pathogens, including: *Anaplasma* spp. such as *Anaplasma phagocytophilum*, *Rickettsia* spp. from the spotted fever group, *Candidatus* Neoehrlichia mikurensis, *Ehrlichia* spp., *Bartonella* spp., *Francisella tularensis*, and *Coxiella burnetii* (Parola and Raoult, [@B31]; Cotte et al., [@B8]; Fertner et al., [@B17]). Ticks can also transmit *Babesia* genus protozoa, such as *Babesia divergens* or the newly described *Babesia venatorum* (sp. EU1) and *Theileria* spp. (Bishop et al., [@B2]; Bonnet et al., [@B3]).

Increased human travel, animal transport, and environmental changes are responsible for the emergence and/or spread of numerous tick-borne pathogens (TBPs) in Europe (Dantas-Torres et al., [@B10]). Therefore, effective tick-based surveillance is essential for monitoring human and/or animal disease emergence (Diuk-Wasser et al., [@B15]). Ticks harbor a variety of pathogens, some of which are obligate intracellular organisms and/or are impossible to artificially culture. Consequently, molecular approaches are thus indispensable for TBP identification. In conventional amplification-based assays, TBP detection occurs for a restricted number of target pathogens known to be transmitted by certain tick species collected at particular sites (Cotte et al., [@B7]). The main disadvantage of this approach is the limited number of different targets that can be tested, given the quantity of DNA required for one PCR. To improve surveillance of human and animal diseases, new investigative tools are required which perform high-throughput testing of a wider panel of TBPs.

Therefore, the aim of this study was to conduct high-throughput monitoring of tick-borne human and animal pathogens in Europe. Accordingly, we developed a novel high-throughput epidemiological surveillance method to identify both major and neglected European TBPs (bacteria and parasites). This tool utilizes a microfluidic system (BioMark™ dynamic array system, Fluidigm) that is capable of performing parallel real-time PCRs using either 96.96 chips or 48.48 chips resulting in either 9216 or 2304 individual reactions, respectively (Liu et al., [@B25]). In a single experiment, 94 ticks or pools of ticks can be tested for the presence of 25 bacteria and 12 parasites, as well as confirmation of the tick species. As only a few microliters of sample are required for each test, this system can also be used in conjuction with the typically low-volume DNA extracts prepared from ticks. Then we applied this method to screen 7050 *Ixodes ricinus* collected from three European countries; France, Denmark, and the Netherlands. We demonstrated increased surveillance efficiency of major and neglected TBPs, and improved monitoring of the emerging diseases important to public and animal health.

Materials and methods {#s2}
=====================

Study area and tick collection
------------------------------

A total of 7050 *Ixodes ricinus* nymphs, from six different locations in France, Denmark, and the Netherlands, divided in 47 pools of 25 nymphs per site, were studied. Questing nymphs were collected using the flagging technique (Vassallo et al., [@B43]). In France, ticks were collected from Murbach (F1) (N 47° 55′, E 7° 9′) and Wasselonne (F2) (N 48° 37′, E 7° 27′) in 2011. In Denmark, ticks were collected from Vestskoven (D1) (N 55° 42′, E 12° 21′) and Grib Skov (D2) (N 56° 02′, E 12° 20′) in 2012. In the Netherlands, ticks were collected from the Duin en Kruidberg area (N1) (N 52° 17′, E 4° 49′) in 2010 and 2011, and from the Austerlitz area (N2) (N 52° 5′, E 5° 18′) over a period from 2008 to 2012.

DNA extraction
--------------

Ticks were morphologically identified to species level (Pérez-Eid, [@B32]) and preserved at −80°C. After washing once in 70% ethanol for 5 min and twice in distilled water for 5 min, pools of 25 nymphs were crushed in 300 μl of DMEM with 10% fetal calf serum and six steel balls using the homogenizer Precellys®24 Dual (Bertin, France) at 5500 rpm for 20 s.

DNA was then extracted using the Wizard genomic DNA purification kit (Promega, France). Total DNA per sample was eluted in 50 μl of rehydration solution and stored at −20°C until further use.

Primers and probe design
------------------------

Pathogens, targeted genes and primers/probe sets are listed in Table [1](#T1){ref-type="table"}. For each pathogen or tick, primers and probes were specifically designed for this study. Each primer or probe set was validated on dilution range of several positive controls (Table [1](#T1){ref-type="table"}) and real-time TaqMan PCRs on a LightCycler® 480 (LC480) (Roche Applied Science, Germany). Real-time PCR assays were performed in a final volume of 12 μl using the LightCycler® 480 Probe Master Mix 1× (Roche Applied Science, Germany), with primers and probes at 200 nM and 2 μl of control DNA. Thermal cycling conditions were as follows: 95°C for 5 min, 45 cycles at 95°C for 10 s and 60°C for 15 s and one final cooling cycle at 40°C for 10 s. Four pathogens (*Borrelia valaisiana*, *Francisella tularensis*, *Coxiella burnetii*, and *Theileria annulata*) were targeted by real-time PCRs on two different sequences to improve detection.

###### 

**List of pathogens, tick species, targets, primers/probe sets, and positive controls**.

  **Species**                            **Target**   **Name**          **Sequence**                     **Length (bp)**   **Positive control**
  -------------------------------------- ------------ ----------------- -------------------------------- ----------------- --------------------------------------------------
  *Borrelia burgdorferi* sensu stricto   *rpoB*       Bo_bu_rpoB_F      GCTTACTCACAAAAGGCGTCTT           83                Culture of B31 strain
                                                      Bo_bu_rpoB_R      GCACATCTCTTACTTCAAATCCT                            
                                                      Bo_bu_rpoB_P      AATGCTCTTGGACCAGGAGGACTTTCA                        
  *Borrelia garinii*                     *rpoB*       Bo_ga_rpoB_F      TGGCCGAACTTACCCACAAAA            88                Culture of NE11 strain
                                                      Bo_ga_rpoB_R      ACATCTCTTACTTCAAATCCTGC                            
                                                      Bo_ga_rpoB_P      TCTATCTCTTGAAAGTCCCCCTGGTCC                        
  *Borrelia afzelii*                     *fla*        Bo_af_fla_F       GGAGCAAATCAAGATGAAGCAAT          116               Culture of VS641 strain
                                                      Bo_af_fla_R       TGAGCACCCTCTTGAACAGG                               
                                                      Bo_af_fla_P       TGCAGCCTGAGCAGCTTGAGCTCC                           
  *Borrelia valaisiana*                  *ospE*       Bo_val_ospE_F     GAAACTTAGGGAGTATCTTATGAAT        143               Culture of VS116 strain
                                                      Bo_val_ospE_R     CTTGCCCCCTTAAACTAATATCT                            
                                                      Bo_val_ospE_P     TGCTCACTCAACCTGCCTTGCTCGC                          
                                         *ospA*       Bo_va_ospA_F      ACTCACAAATGACAGATGCTGAA          135               
                                                      Bo_va_ospA_R      GCTTGCTTAAAGTAACAGTACCT                            
                                                      Bo_va_ospA_P      TCCGCCTACAAGATTTCCTGGAAGCTT                        
  *Borrelia miyamotoi*                   *glpQ*       B_miya_glpQ_F     CACGACCCAGAAATTGACACA            94                Plasmid[^a^](#TN3){ref-type="table-fn"}
                                                      B_miya_glpQ_R     GTGTGAAGTCAGTGGCGTAAT                              
                                                      B_miya_glpQ_P     TCGTCCGTTTTCTCTAGCTCGATTGGG                        
  *Borrelia spielmanii*                  *fla*        Bo_spi_fla_F      ATCTATTTTCTGGTGAGGGAGC           71                Plasmid[^a^](#TN3){ref-type="table-fn"}
                                                      Bo_spi_fla_R      TCCTTCTTGTTGAGCACCTTC                              
                                                      Bo_spi_fla_P      TTGAACAGGCGCAGTCTGAGCAGCTT                         
  *Borrelia lusitaniae*                  *rpoB*       Bo_lus_rpoB_F     CGAACTTACTCATAAAAGGCGTC          87                Culture of Poti-B1 strain
                                                      Bo_lus_rpoB_R     TGGACGTCTCTTACTTCAAATCC                            
                                                      Bo_lus_rpoB_P     TTAATGCTCTCGGGCCTGGGGGACT                          
  *Borrelia bissettii*                   *rpoB*       Bo_bi_rpoB_F      GCAACCAGTCAGCTTTCACAG            118               Plasmid[^a^](#TN3){ref-type="table-fn"}
                                                      Bo_bi_rpoB_R      CAAATCCTGCCCTATCCCTTG                              
                                                      Bo_bi_rpoB_P      AAAGTCCTCCCGGCCCAAGAGCATTAA                        
  *Borrelia* spp.                        23S rRNA     Bo_bu_sl_23S_F    GAGTCTTAAAAGGGCGATTTAGT          73                
                                                      Bo_bu_sl_23S_R    CTTCAGCCTGGCCATAAATAG                              
                                                      Bo_bu_sl_23S_P    AGATGTGGTAGACCCGAAGCCGAGT                          
  *Anaplasma marginale*                  *msp1b*      An_ma_msp1_F      CAGGCTTCAAGCGTACAGTG             85                Experimentally infected cow
                                                      An_ma_msp1_R      GATATCTGTGCCTGGCCTTC                               
                                                      An_ma_msp1_P      ATGAAAGCCTGGAGATGTTAGACCGAG                        
  *Anaplasma platys*                     *groEL*      An_pla_groEL_F    TTCTGCCGATCCTTGAAAACG            75                Infected dog blood
                                                      An_pla_groEL_R    CTTCTCCTTCTACATCCTCAG                              
                                                      An_pla_groEL_P    TTGCTAGATCCGGCAGGCCTCTGC                           
  *Anaplasma ovis*                       *msp4*       An_ov_msp4_F      TCATTCGACATGCGTGAGTCA            92                Plasmid[^a^](#TN3){ref-type="table-fn"}
                                                      An_ov_msp4_R      TTTGCTGGCGCACTCACATC                               
                                                      An_ov_msp4_P      AGCAGAGAGACCTCGTATGTTAGAGGC                        
  *Anaplasma centrale*                   *groEL*      An_cen_groEL_F    AGCTGCCCTGCTATACACG              79                Plasmid[^a^](#TN3){ref-type="table-fn"}
                                                      An_cen_groEL_R    GATGTTGATGCCCAATTGCTC                              
                                                      An_cen_groEL_P    CTTGCATCTCTAGACGAGGTAAAGGGG                        
  *Anaplasma phagocytophilum*            *msp2*       An_ph_msp2_F      GCTATGGAAGGCAGTGTTGG             77                Infected embrionary cells of *Ixodes scapularis*
                                                      An_ph_msp2_R      GTCTTGAAGCGCTCGTAACC                               
                                                      An_ph_msp2_P      AATCTCAAGCTCAACCCTGGCACCAC                         
  *Ehrlichia ruminantium*                *dsb*        Eh_ru_dsb_F       CTCAGAGGGTAATAGATTTACTC          107               Culture of Gardel strain
                                                      Eh_ru_dsb_R       GTATGCAATATCTTCAAGCTCAG                            
                                                      Eh_ru_dsb_P       ACTACAGGCCAAGCACAAGCAGAAAGA                        
  *Ehrlichia canis*                      *dsb*        Eh_ca_dsb_F       AATACTTGGTGAGTCTTCACTCA          110               Plasmid[^a^](#TN3){ref-type="table-fn"}
                                                      Eh_ca_dsb_R       GTTGCTTGTAATGTAGTGCTGC                             
                                                      Eh_ca_dsb_P       AAGTTGCCCAAGCAGCACTAGCTGTAC                        
  *Ehrlichia chaffeensis*                *dsb*        Eh_ch_dsb_F       TATTGCTAATTACCCTCAAAAAGTC        117               Infected wild *Amblyomma americanum*
                                                      Eh_ch_dsb_R       GAGCTATCCTCAAGTTCAGATTT                            
                                                      Eh_ch_dsb_P       ATTGACCTCCTAACTAGAGGGCAAGCA                        
  *Candidatus* Neoehrlichia mikurensis   *groEL*      Neo_mik_groEL_F   AGAGACATCATTCGCATTTTGGA          96                Infected tick
                                                      Neo_mik_groEL_R   TTCCGGTGTACCATAAGGCTT                              
                                                      Neo_mik_groEL_P   AGATGCTGTTGGATGTACTGCTGGACC                        
  *Rickettsia conorii*                   23S-5S ITS   Ri_co_ITS_F       CTCACAAAGTTATCAGGTTAAATAG        118               Culture
                                                      Ri_co_ITS_R       CGATACTCAGCAAAATAATTCTCG                           
                                                      Ri_co_ITS_P       CTGGATATCGTGGCAGGGCTACAGTAT                        
  *Rickettsia slovaca*                   23S-5S ITS   Ri_slo_ITS_F      GTATCTACTCACAAAGTTATCAGG         138               Culture
                                                      Ri_slo_ITS_R      CTTAACTTTTACTACAATACTCAGC                          
                                                      Ri_slo_ITS_P      TAATTTTCGCTGGATATCGTGGCAGGG                        
  *Rickettsia massiliae*                 23S-5S ITS   Ri_ma_ITS_F       GTTATTGCATCACTAATGTTATACTG       128               Culture
                                                      Ri_ma_ITS_R       GTTAATGTTGTTGCACGACTCAA                            
                                                      Ri_ma_ITS_P       TAGCCCCGCCACGATATCTAGCAAAAA                        
  *Rickettsia helvetica*                 23S-5S ITS   Ri_he_ITS_F       AGAACCGTAGCGTACACTTAG            79                Culture
                                                      Ri_he_ITS_R       GAAAACCCTACTTCTAGGGGT                              
                                                      Ri_he_ITS_P       TACGTGAGGATTTGAGTACCGGATCGA                        
  Spotted fever group                    *gltA*       SFG_gltA_F        CCTTTTGTAGCTCTTCTCATCC           145               
                                                      SFG_gltA_R        GCGATGGTAGGTATCTTAGCAA                             
                                                      SFG_gltA_P        TGGCTATTATGCTTGCGGCTGTCGGT                         
  *Bartonella henselae*                  *pap31*      Bar_he_pap31_F    CCGCTGATCGCATTATGCCT             107               Culture of Berlin 1 strain
                                                      Bar_he_pap31_R    AGCGATTTCTGCATCATCTGCT                             
                                                      Bar_he_pap31_P    ATGTTGCTGGTGGTGTTTCCTATGCAC                        
  *Bartonella quintana*                  *bqtR*       Bar_qu_bqt_F      TCCATCACAAGATCTCCGCG             80                Culture
                                                      Bar_qu_bqt_R      CGTGCCAATGCTCGTAACCA                               
                                                      Bar_qu_bqt_P      TTTAAGAGAGGAGGTAGAAGAGGCTCC                        
  *Francisella tularensis*               *tul4*       Fr_tu_tul4_F      ACCCACAAGGAAGTGTAAGATTA          76                Culture of CIP 5612T strain
                                                      Fr_tu_tul4_R      GTAATTGGGAAGCTTGTATCATG                            
                                                      Fr_tu_tul4_P      AATGGCAGGCTCCAGAAGGTTCTAAGT                        
                                         *fopA*       Fr_tu_fopA_F      GGCAAATCTAGCAGGTCAAGC            91                
                                                      Fr_tu_fopA_R      CAACACTTGCTTGAACATTTCTAG                           
                                                      Fr_tu_fopA_P      AACAGGTGCTTGGGATGTGGGTGGTG                         
  *Coxiella burnettii*                   *idc*        Co_bu_icd_F       AGGCCCGTCCGTTATTTTACG            74                Culture
                                                      Co_bu_icd_R       CGGAAAATCACCATATTCACCTT                            
                                                      Co_bu_icd_P       TTCAGGCGTTTTGACCGGGCTTGGC                          
                                         IS*1111*     Co_bu_IS111_F     TGGAGGAGCGAACCATTGGT             86                
                                                      Co_bu_IS111_R     CATACGGTTTGACGTGCTGC                               
                                                      Co_bu_IS111_P     ATCGGACGTTTATGGGGATGGGTATCC                        
  *Babesia divergens*                    *hsp70*      Bab_di_hsp70_F    CTCATTGGTGACGCCGCTA              83                Culture of RFS strain
                                                      Bab_di_hsp70_R    CTCCTCCCGATAAGCCTCTT                               
                                                      Bab_di_hsp70_P    AGAACCAGGAGGCCCGTAACCCAGA                          
  *Babesia caballi*                      *Rap1*       Ba_cab_rap1_F     GTTGTTCGGCTGGGGCATC              94                Plasmid[^a^](#TN3){ref-type="table-fn"}
                                                      Ba_cab_rap1_R     CAGGCGACTGACGCTGTGT                                
                                                      Ba_cab_rap1_P     TCTGTCCCGATGTCAAGGGGCAGGT                          
  *Babesia canis*                        18S rRNA     Ba_ca_RNA18S_F    TGGCCGTTCTTAGTTGGTGG             104               Infected dog blood
                                                      Ba_ca_RNA18S_R    AGAAGCAACCGGAAACTCAAATA                            
                                                      Ba_ca_RNA18S_P    ACCGGCACTAGTTAGCAGGTTAAGGTC                        
  *Babesia vogeli*                       *hsp70*      Ba_vo_hsp70_F     TCACTGTGCCTGCGTACTTC             87                Infected dog blood
                                                      Ba_vo_hsp70_R     TGATACGCATGACGTTGAGAC                              
                                                      Ba_vo_hsp70_P     AACGACTCCCAGCGCCAGGCCAC                            
  *Babesia venatorum* (sp. EU1)          18S rRNA     Bab_EU_RNA18S_F   GCGCGCTACACTGATGCATT             91                Plasmid[^a^](#TN3){ref-type="table-fn"}
                                                      Bab_EU_RNA18S_R   CAAAAATCAATCCCCGTCACG                              
                                                      Bab_EU_RNA18S_P   CATCGAGTTTAATCCTGTCCCGAAAGG                        
  *Babesia microti*                      *CCTeta*     Bab_mi_CCTeta_F   ACAATGGATTTTCCCCAGCAAAA          145               Culture of R1 strain
                                                      Bab_mi_CCTeta_R   GCGACATTTCGGCAACTTATATA                            
                                                      Bab_mi_CCTeta_P   TACTCTGGTGCAATGAGCGTATGGGTA                        
  *Babesia bovis*                        *CCTeta*     Ba_bo_CCTeta_F    GCCAAGTAGTGGTAGACTGTA            100               Culture of MO7 strain
                                                      Ba_bo_CCTeta_R    GCTCCGTCATTGGTTATGGTA                              
                                                      Ba_bo_CCTeta_P    TAAAGACAACACTGGGTCCGCGTGG                          
  *Babesia bigemina*                     18S rRNA     Ba_big_RNA18S_F   ATTCCGTTAACGAACGAGACC            99                Plasmid[^a^](#TN3){ref-type="table-fn"}
                                                      Ba_big_RNA18S_R   TTCCCCCACGCTTGAAGCA                                
                                                      Ba_big_RNA18S_P   CAGGAGTCCCTCTAAGAAGCAAACGAG                        
  *Babesia major*                        *CCTeta*     Ba_maj_CCTeta_F   CACTGGTGCGCTGATCCAA              75                Plasmid[^a^](#TN3){ref-type="table-fn"}
                                                      Ba_maj_CCTeta_R   TCCTCGAAGCATCCACATGTT                              
                                                      Ba_maj_CCTeta_P   AACACTGTCAACGGCATAAGCACCGAT                        
  *Babesia ovis*                         18S rRNA     Ba_ov_RNA18S_F    TCTGTGATGCCCTTAGATGTC            92                Plasmid[^a^](#TN3){ref-type="table-fn"}
                                                      Ba_ov_RNA18S_R    GCTGGTTACCCGCGCCTT                                 
                                                      Ba_ov_RNA18S_P    TCGGAGCGGGGTCAACTCGATGCAT                          
  *Theileria equi*                       *ema1*       Th_eq_ema1_F      GGCTCCGGCAAGAAGCACA              66                Plasmid[^a^](#TN3){ref-type="table-fn"}
                                                      Th_eq_ema1_R      CTTGCCATCGACGACCTTGA                               
                                                      Th_eq_ema1_P      CTTCAAGGCTCCAGGCAAGCGCGT                           
  *Theileria annulata*                   18S rRNA     Th_an_18S_F       GCGGTAATTCCAGCTCCAATA            126               Culture of D7 strain
                                                      Th_an_18S_R       AAACTCCGTCCGAAAAAAGCC                              
                                                      Th_an_18S_P       ACATGCACAGACCCCAGAGGGACAC                          
                                         *Tams1*      Th_an_Tams1_F     CGATTACAAACCAGTTGTCGAC           82                
                                                      Th_an_Tams1_R     GTAAAGGACTGATGAGAAGACG                             
                                                      Th_an_Tams1_P     TGAGTACTGAGGCGAAGACTGCAAGG                         
  *Ixodes ricinus*                       ITS2         Ix_ri_ITS2_F      CGAAACTCGATGGAGACCTG             77                Tick
                                                      Ix_ri_ITS2_R      ATCTCCAACGCACCGACGT                                
                                                      Ix_ri_ITS2_P      TTGTGGAAATCCCGTCGCACGTTGAAC                        
  *Ixodes persulcatus*                   ITS2         Ix_pe_ITS2_F      TGCGTTGCGTCTTCTCTTGTT            111               Tick
                                                      Ix_pe_ITS2_R      TCGATAAAACCAGGTAGGAGGA                             
                                                      Ix_pe_ITS2_P      TTTCGGAGCAAGTACAGAGGGAGCAAA                        
  *Ixodes hexagonus*                     ITS2         Ix_hex_ITS2_F     CCGCCGTTGGGATTTACGA              90                Tick
                                                      Ix_hex_ITS2_R     GTTCCTCCGACCCACTTTC                                
                                                      Ix_hex_ITS2_P     AGCGCCTTAAAAGAATCGGCAACCTCT                        
  *Dermacentor reticulatus*              ITS2         De_re_ITS2_F      AACCCTTTTCCGCTCCGTG              83                Tick
                                                      De_re_ITS2_R      TTTTGCTAGAGCTCGACGTAC                              
                                                      De_re_ITS2_P      TACGAAGGCAAACAACGCAAACTGCGA                        
  *Dermacentor marginatus*               ITS2         De_ma_ITS2_F      GCACGTTGCGTTGTTTGCC              139               Tick
                                                      De_ma_ITS2_R      CCGCTCCGCGCAAGAATCT                                
                                                      De_ma_ITS2_P      TTCGGAGTACGTCGAGCTCTAGCAGA                         
  *Escherichia coli*                     *eae*        eae-F2            CATTGATCAGGATTTTTCTGGTGATA       102               Culture of EDL933 strain
                                                      eae-R             CTCATGCGGAAATAGCCGTTA                              
                                                      eae-P             ATAGTCTCGCCAGTATTCGCCACCAATACC                     

*Plasmids are recombinant pBluescript IISK+ containing the target gene*.

DNA pre-amplification
---------------------

For DNA pre-amplification, the TaqMan PreAmp Master Mix (Applied Biosystems, France) was used according to the manufacturer\'s instructions. Primers (except those which target tick DNA) were pooled combining equal volume of primers (200 nM final each). The reaction was performed in a final volume of 5 μ l containing 2.5 μ l TaqMan PreAmp Master Mix, 1.2 μ l pooled primers mix and 1.3 μ l DNA, with one cycle at 95°C for 10 min, 14 cycles at 95°C for 15 s and 4 min at 60°C. At the end of the cycling program the reactions were diluted 1:10. Pre-amplified DNAs were stored at −20°C until needed.

High-throughput real-time PCR system
------------------------------------

The BioMark™ real-time PCR system (Fluidigm, USA) was used for high-throughput microfluidic real-time PCR amplification using either the 96.96 or the 48.48 dynamic arrays (Fluidigm). These chips dispense 96 (or 48) PCR mixes and 96 (or 48) samples into individual wells, after which on-chip microfluidics assemble PCR reactions in individual chambers prior to thermal cycling resulting in either 9216 or 2304 individual reactions.

Amplifications were performed using 6-carboxyfluorescein (FAM)- and black hole quencher (BHQ1)-labeled TaqMan probes with TaqMan Gene expression master mix in accordance with manufacturer\'s instructions (Applied Biosystems, France). A 6 μ l sample mix was prepared per sample, containing 3 μl TaqMan® Gene expression Master Mix (Applied Biosystems, Foster City, CA), 0.3 μl sample Loading Reagent (Fluidigm PN 85000746) and 2.7 μl of diluted pre-amplified DNA. A TaqMan® primer assay was prepared for each target, containing 18 μM of each primer and 4 μM of probe. Three microliters of these primer assays were mixed with equal volumes of Dynamic Array (DA) assay loading reagent (Fluidigm PN 85000736) to make assay mixes (9 μ M primers and 2 μ M probe). Prior to loading the samples and assay mixes into the inlets, the chip was primed in the IFC Controller HX apparatus. Five μl of sample mixes, prepared as described, were then loaded into each sample inlet of the dynamic array chip and 5 μ l of assay mixes were loaded into assay inlets. The chip was then placed on the IFC Controller HX for loading and mixing. After approximately 45 min the chip was ready for thermal cycling and detection of the reaction products on the Biomark. PCR cycling comprised of 2 min at 50°C, 10 min at 95°C, followed by 40 cycles of 2-step amplification of 15 s at 95°C, and 1 min at 60°C. Data were acquired on the BioMark™ Real-Time PCR System and analyzed using the Fluidigm Real-time PCR Analysis software to obtain crossing point (CP) values.

For microfluidic tool evaluation on field samples, the assays were performed in duplicate. Two negative water controls were included per chip. *Ixodes ricinus* DNA served to confirm the tested tick species and as a DNA extraction control. To determine if factors present in the sample could inhibit the PCR, *Escherichia coli* strain EDL933 DNA was added to each sample as an internal inhibition control. Primers and probe specific for the *E. coli eae* gene (Nielsen and Andersen, [@B28]) were used for an internal control.

Validation of the results by PCR and sequencing
-----------------------------------------------

Conventional PCR using primers targeting different genes or regions than those of the BioMark™ system (Table [2](#T2){ref-type="table"}), were used to confirm the presence of pathogenic DNA in the field samples. Amplicons were sequenced by Eurofins MWG Operon (Germany), and then assembled using BioEdit software (Ibis Biosciences, Carlsbad). An online BLAST (National Center for Biotechnology Information) was used to compare results with published sequences listed in GenBank sequence databases.

###### 

**Primers used to confirm the presence of pathogenic DNA in ticks**.

  **Pathogen**                  **Targeted gene**   **Primer name**   **Sequence (5′ → 3′)**           **Amplicon size (bp)**   **References**
  ----------------------------- ------------------- ----------------- -------------------------------- ------------------------ -----------------------------
  *Borrelia* spp.               *clpA*              clpAF1240         GATAGATTTCTTCCAGACAAAG           975                      Margos et al., [@B26]
                                                    clpAR2214         TTCATCTATTAAAAGCTTTCCC                                    
                                                    clpAF1255         GACAAAGCTTTTGATATTTTAG           850                      
                                                    clpAR2104         CAAAAAAAACATCAAATTTTCTATCTC                               
  *Bartonella* spp.             16S-23S IGS         P-bhenfa          TCTTCGTTTCTCTTTCTTCA             186                      Rampersad et al., [@B33]
                                                    P-benr1           CAAGCGCGCGCTCTAACC                                        
                                                    N-bhenf1a         GATGATCCCAAGCCTTCTGGC            149                      
                                                    N-benr            AACCAACTGAGCTACAAGCC                                      
  *Anaplasma phagocytophilum*   *msp4*              MSP4AP5           ATGAATTACAGAGAATTGCTTGTAGG       849                      De La Fuente et al., [@B12]
                                                    MSP4AP3           TTAATTGAAAGCAAATCTTGCTCCTATG                              
  *Candidatus* N. mikurensis    *groEL*             NM 1152as         TTCTACTTTGAACATTTGAAGAATTACTAT   1024                     Diniz et al., [@B14]
                                                    NM 128s           AACAGGTGAAACACTAGATAAGTCCAT                               
  *Rickettsia* spp.             *gltA*              Rsfg877           GGGGGCCTGCTCACGGCGG              381                      Regnery et al., [@B34]
                                                    Rsfg1258          ATTGCAAAAAGTACAGTGAACA                                    
  *Babesia* spp.                18S rRNA            BabGF2            GYYTTGTAATTGGAATGATGG            559                      Bonnet et al., [@B4]
                                                    BabGR2            CCAAAGACTTTGATTTCTCTC                                     

Prevalence estimation
---------------------

Prevalences were estimated assuming perfect sensitivity and specificity of pathogen detection using the online statistical program "Pooled prevalence for fixed pool size and perfect test" Method 2 (AusVet Animal Health Service <http://epitools.ausvet.com.au/content.php?page=home>). Point estimates were based on the maximum likelihood method developed by Kline et al. ([@B24]). Exact 95% confidence intervals were obtained by assuming binomial distribution for the number of positive pools (Cowling et al., [@B9]). If all pools were positive, prevalence was recorded as \>14.3%, as the highest prevalence that can be distinguished from 100% when testing 47 pools of 25 ticks. If all pools were negative, prevalence was recorded as \<0.25%, since the 95% probability of sampling *n* negative ticks from a population with prevalence *p* is given as (1 − *p*)^*n*^.

Results {#s3}
=======

Implementation of high-throughput real-time PCR system to detect TBPs
---------------------------------------------------------------------

Primers and probes were specially designed to detect 37 TBPs and 4 tick species (Table [1](#T1){ref-type="table"}). Each set of primers and probes specifically identified their corresponding positive control samples via Taqman real-time PCRs on a LightCycler 480 apparatus. Resulting CP values varied from 8 to 40 depending on sample type. Among the 37 TBP DNAs used as positive controls, 10 were not detected by the BioMark™ system. Consequently, an initial step of DNA pre-amplification was added, which enabled detection of all positive controls. Subsequently all tick DNA samples were pre-amplified prior to pathogen detection on the BioMark™ system. The specificity of each primer set was then evaluated using 37 TBPs, and 4 tick species positive controls (Figure [1](#F1){ref-type="fig"}). Results demonstrated high specificity for each primers/probe set after pre-amplification, using a cut-off of 30 CP (Figure [1](#F1){ref-type="fig"}). Indeed, 45 assays were only positive for the corresponding positive control. Three assays showed cross-reactivity with other pathogen targets. The assay for *B. burgdorferi* sensu stricto cross-reacted with *B. garinii* and *B. valaisiana* DNA. The assay targeting *R. conorii* cross-reacted with *R. massiliae*, as well as with *R. slovaca* DNA, cross-reactivity was also observed reciprocally.

![**BioMark™ dynamic array system specificity test (48.48 chip)**. Each square corresponds to a single real-time PCR reaction, where rows indicate the pathogen in the positive control and columns represent the targets of each primers/probe set. CP values for each reaction are indicated by color; the corresponding color scale is presented in the legend on the right. The darkest shade of blue and black squares are considered as negative reactions with *CP* \> 30.](fcimb-04-00103-g0001){#F1}

Large scale prevalence study of TBPs
------------------------------------

A total of 7050 nymphs, in 47 pools of 25, from six different European sites were tested using the BioMark™ system. Among the targeted pathogens, 15 bacteria (*B. lusitaniae*, *B. bissettii*, *A. marginale*, *A. platys*, *A. ovis*, *A. centrale, E. ruminantium*, *E. canis*, *E. chaffeensis, R. conorii*, *R. slovaca*, *R. massiliae, B. quintana, F. tularensis*, and *C. burnetii*) and 10 parasites (*B. caballi*, *B. canis*, *B. vogeli*, *B. microti*, *B. bovis*, *B. bigemina*, *B. major*, *B. ovis*, *T. equi*, and *T. annulata*) were not detected in any country. The number of positive pools for each pathogen is presented in Table [3](#T3){ref-type="table"} and the prevalence was estimated at each site of collection (Table [4](#T4){ref-type="table"}).

###### 

**Number of positive pools of ticks out of the 47 tested, for two sites in France, Denmark, and the Netherlands using the microfluidic tool (BioMark™ system)**.

                                   **Number of positive pools (out of 47 tested)**                                       
  -------------------------------- ------------------------------------------------- -------- -------- -------- -------- --------
  *Borrelia* spp.                  **32**                                            **33**   **47**   **40**   **38**   **44**
  *B. burgdorferi* sensu stricto   **0**                                             **1**    **31**   **29**   **14**   **6**
  *B. garinii*                     **5**                                             **8**    **19**   **36**   **20**   **17**
  *B. afzelii*                     **13**                                            **17**   **46**   **32**   **20**   **36**
  *B. valaisiana*                  **1**                                             **1**    **13**   **11**   **6**    **1**
  *B. spielmanii*                  **1**                                             **1**    **10**   **17**   **3**    **1**
  *B. miyamotoi*                   **22**                                            **10**   **13**   **2**    **20**   **27**
  *B. lusitaniae*                  0                                                 0        0        0        0        0
  *B. bissettii*                   0                                                 0        0        0        0        0
  *Anaplasma marginale*            0                                                 0        0        0        0        0
  *Anaplasma platys*               0                                                 0        0        0        0        0
  *Anaplasma ovis*                 0                                                 0        0        0        0        0
  *Anaplasma centrale*             0                                                 0        0        0        0        0
  *Anaplasma phagocytophilum*      **8**                                             **12**   **4**    **45**   **10**   **19**
  *Ehrlichia ruminantium*          0                                                 0        0        0        0        0
  *Ehrlichia canis*                0                                                 0        0        0        0        0
  *Ehrlichia chaffeensis*          0                                                 0        0        0        0        0
  *Candidatus* N. mikurensis       **13**                                            **2**    **10**   **2**    **28**   **41**
  Spotted fever group              **46**                                            **46**   **44**   **47**   **45**   **32**
  *Rickettsia conorii*             0                                                 0        0        0        0        0
  *Rickettsia slovaca*             0                                                 0        0        0        0        0
  *Rickettsia massiliae*           0                                                 0        0        0        0        0
  *Rickettsia helvetica*           **46**                                            **46**   **44**   **46**   **45**   **32**
  *Bartonella henselae*            **0**                                             **1**    **0**    **0**    **0**    **0**
  *Bartonella quintana*            0                                                 0        0        0        0        0
  *Francisella tularensis*         0                                                 0        0        0        0        0
  *Coxiella burnetii*              0                                                 0        0        0        0        0
  *Babesia divergens*              **0**                                             **0**    **1**    **1**    **0**    **2**
  *Babesia caballi*                0                                                 0        0        0        0        0
  *Babesia canis*                  0                                                 0        0        0        0        0
  *Babesia vogeli*                 0                                                 0        0        0        0        0
  *Babesia venatorum* (sp. EU1)    **2**                                             **3**    **14**   **5**    **0**    **9**
  *Babesia microti*                0                                                 0        0        0        0        0
  *Babesia bovis*                  0                                                 0        0        0        0        0
  *Babesia bigemina*               0                                                 0        0        0        0        0
  *Babesia major*                  0                                                 0        0        0        0        0
  *Babesia ovis*                   0                                                 0        0        0        0        0
  *Theileria equi*                 0                                                 0        0        0        0        0
  *Theileria annulata*             0                                                 0        0        0        0        0

*Bold values represent pathogens detected at least in one site*.

###### 

**Estimated prevalence of pathogens detected in *Ixodes ricinus* in France, Denmark, and the Netherlands**.

                                   **Estimated prevalence % (95% CI)**                                                                                                                                                                            
  -------------------------------- ---------------------------------------- ---------------------------------------- ----------------------------------------- ----------------------------------------- ---------------------------------------- ----------------------------------------
  *Borrelia* spp.                  4.47 (2.97--6.41)                        4.73 (3.15--6.77)                        \>14.27[^b^](#TN2){ref-type="table-fn"}   7.33 (4.92--10.52)                        6.40 (4.31--9.12)                        10.42 (6.73--15.85)
  *B. burgdorferi* sensu stricto   \<0.25[^a^](#TN1){ref-type="table-fn"}   0.09 (0.00--0.48)                        4.22 (2.79--6.08)                         3.77 (2.46--5.47)                         1.40 (0.76--2.36)                        0.54 (0.20--1.18)
  *B. garinii*                     0.45 (0.14--1.05)                        0.74 (0.32--1.46)                        2.05 (1.22--3.21)                         5.64 (3.79--8.04)                         2.19 (1.32--3.39)                        1.78 (1.02--2.85)
  *B. afzelii*                     1.29 (0.68--2.20)                        1.78 (1.02--2.85)                        14.27 (8.35--26.0)                        4.47 (2.97--6.41)                         2.19 (1.32--3.39)                        5.64 (3.79--8.04)
  *B. valaisiana*                  0.09 (0.00--0.48)                        0.09 (0.00--0.48)                        1.29 (0.68--2.20)                         1.06 (0.52--1.90)                         0.54 (0.20--1.18)                        0.09 (0.00--0.48)
  *B. spielmanii*                  0.09 (0.00--0.48)                        0.09 (0.00--0.48)                        0.95 (0.45--1.75)                         1.78 (1.02--2.85)                         0.26 (0.05--0.77)                        0.09 (0.00--0.48)
  *B. miyamotoi*                   2.49 (1.54--3.79)                        0.95 (0.45--1.75)                        1.29 (0.68--2.20)                         0.17 (0.02--0.63)                         2.19 (1.32--3.39)                        3.36 (2.17--4.93)
  *Anaplasma phagocytophilum*      0.74 (0.32--1.46)                        1.17 (0.60--2.05)                        0.36 (0.10--0.91)                         11.86 (7.42--18.97)                       0.95 (0.45--1.75)                        2.05 (1.22--3.21)
  *Candidatus* N. mikurensis       1.29 (0.68--2.20)                        0.17 (0.02--0.63)                        0.95 (0.45--1.75)                         0.17 (0.02--0.63)                         3.56 (2.31--5.19)                        7.90 (5.28--11.41)
  Spotted fever group              14.27 (8.35--26.0)                       14.27 (8.35--26.0)                       10.42 (6.73--15.85)                       \>14.27[^b^](#TN2){ref-type="table-fn"}   11.86 (7.42--18.97)                      4.47 (2.97--6.41)
  *Rickettsia helvetica*           14.27 (8.35--26.0)                       14.27 (8.35--26.0)                       10.42 (6.73--15.85)                       14.27 (8.35--26.0)                        11.86 (7.42--18.97)                      4.47 (2.97--6.41)
  *Bartonella henselae*            \<0.25[^a^](#TN1){ref-type="table-fn"}   0.09 (0.00--0.48)                        \<0.25[^a^](#TN1){ref-type="table-fn"}    \<0.25[^a^](#TN1){ref-type="table-fn"}    \<0.25[^a^](#TN1){ref-type="table-fn"}   \<0.25[^a^](#TN1){ref-type="table-fn"}
  *Babesia divergens*              \<0.25[^a^](#TN1){ref-type="table-fn"}   \<0.25[^a^](#TN1){ref-type="table-fn"}   0.09 (0.00--0.48)                         0.09 (0.00--0.48)                         \<0.25[^a^](#TN1){ref-type="table-fn"}   0.17 (0.02--0.63)
  *Babesia venatorum* (sp. EU1)    0.17 (0.02--0.63)                        0.26 (0.05--0.77)                        1.40 (0.76--2.36)                         0.45 (0.14--1.05)                         \<0.25[^a^](#TN1){ref-type="table-fn"}   0.85 (0.38--1.60)

All pools negative;

*all pools positive*.

*Point estimates were based on the maximum likelihood method developed by Kline et al. (16). If all pools were positive, prevalence was recorded as \>14.3%, as the highest prevalence that can be distinguished from 100% when testing 47 pools of 25 ticks. If all pools were negative, prevalence was recorded as \<0.25%, since the 95% probability of sampling n negative ticks from a population with prevalence p is given as (1−p)n*.

In order to confirm the results obtained on the BioMark™ system and to validate this new method, classical PCR and sequencing were performed on extracted DNA for a subset of field samples. All sequences showed at least 99% identity with reference sequences (Table [5](#T5){ref-type="table"}), and have been deposited in GenBank (Accession numbers; KF447526-KF447532, and KF679796). Due to primers which can only detect *Borrelia* and *Babesia* at the genus level, only those samples which tested positive for a single species (and not potentially co-infected samples) were confirmed (Table [2](#T2){ref-type="table"}).

###### 

**Homology between deposited sequences and reference sequences in GenBank**.

  **Species**                     **Nb of samples tested**   **Nb of samples obtained after sequencing**   **Deposited sequence**   **Length (bp)**   **Percentage of identity (%)**   **Reference sequence**
  ------------------------------- -------------------------- --------------------------------------------- ------------------------ ----------------- -------------------------------- ------------------------
  *Borrelia garinii*              1                          1                                             KF447529                 822               99                               AB555782
  *Borrelia afzelii*              1                          1                                             KF447528                 824               99                               JX971251
  *Bartonella henselae*           1                          1                                             KF679796                 149               100                              FJ832091
  *Anaplasma phagocytophilum*     12                         3                                             KF447526                 824               100                              EF067343
  *Candidatus* N. mikurensis      12                         8                                             KF447527                 1012              100                              EU810407
  *Rickettsia helvetica*          12                         9                                             KF447530                 382               100                              JX040636
  *Babesia divergens*             3                          2                                             KF447531                 527               99                               AY572456
  *Babesia venatorum* (sp. EU1)   13                         10                                            KF447532                 562               100                              JQ993425

### France

Among the seven genospecies of *Borrelia burgdorferi* s.l., four were detected in both French sites. *Borrelia afzelii* is the dominant genospecies with a prevalence of 1.8% in F2, as previously described (Beytout et al., [@B1]). The other genospecies (*B. garinii*, *B. valaisiana*, and *B. spielmanii*) had prevalence rates of under 1%. *B. burgdorferi* s.s. was only detected in F2 at low prevalence (0.1%). The relapsing fever spirochete *B. miyamotoi* was detected in both sites, with very different prevalences (2.5% in F1 and 0.9% in F2) and was the most abundant *Borrelia* species in F1. This spirochete has already been detected in France, but only in female adult ticks (Reis et al., [@B35]). *Anaplasma phagocytophilum* was more abundant in F2 (1.2%) and its estimated prevalence is in accordance with a previous study (Beytout et al., [@B1]). *Candidatus* N. mikurensis was more abundant in F1 (1.3%). This pathogen has already been described in bank voles in France (Vayssier-Taussat et al., [@B44]) but this is the first estimation of its prevalence in French ticks. *Rickettsia helvetica* was the only *Rickettsiaceae* identified in this study and was detected in 46/47 pools, showing the highest prevalence (14.3%) of all tested pathogens, much higher than data reported in the literature (1.4--6%) (Cotte et al., [@B7]). *Bartonella henselae* was only detected in F2 (0.1%), in a single pool. Among all assessed parasitic species, *Babesia venatorum* was the only parasite detected in France with a low prevalence (0.2 and 0.3%) as previously described (Reis et al., [@B35]).

### Denmark

Five genospecies of *B. burgdorferi* s.l. were detected in Danish ticks, four previously described (Skarphedinsson et al., [@B37]; Vennestrom et al., [@B45]) and one, *B. spielmanii*, detected for the first time. In previous studies, *B. afzelii* was the most prevalent genospecies (Skarphedinsson et al., [@B37]; Vennestrom et al., [@B45]). In our study, *B. afzelii* was the most prevalent (14.3%) in D1, while *B. garinii* was the most abundant (5.7%) in D2. *B. burgdorferi* s.s. was detected in both sites with similar prevalences (4.2% and 3.8%), as well as *B. valaisiana*, and *B. spielmanii* (approximately 1%). *B. lusitaniae* was identified in a previous study (Vennestrom et al., [@B45]), but was not encountered in the present study. Relapsing fever-causing *B. miyamotoi* was detected for the first time in Danish *I. ricinus* with variable prevalences between the two sites (1.3% in D1 and 0.2% in D2). The estimated prevalence of *A. phagocytophilum* was approximately 30 times higher in D2 (11.9%) than in D1 (0.4%) whereas its prevalence was estimated at 15% in a previous study (Skarphedinsson et al., [@B37]). *Candidatus* N. mikurensis was detected with a low prevalence in the Danish sites (1% in D1 and 0.2% in D2) in agreement with a previous report (Fertner et al., [@B17]). *Rickettsia helvetica* is the only species of *Rickettsia* spp. reported in Denmark. This bacterium was respectively identified in 44 and 46 pools of the samples, corresponding to high prevalences of 10.4% in D1 and 14.3% in D2. In previous reports, the prevalence of *R. helvetica* appeared to vary considerably, ranging from 1.4 to 13% (Svendsen et al., [@B41]; Kantso et al., [@B23]). Two parasitic species were found for the first time in the Danish samples, *B. divergens* (0.1% in D1 and D2) and *B. venatorum* (1.4% in D1 and 0.5% in D2). These parasites have never previously been reported in Danish ticks until now, even if *B. divergens* is frequently found in cattle.

### The Netherlands

Five genospecies of *B. burgdorferi* s.l. were detected in Dutch ticks. *B. garinii* and *B. afzelii* were the more abundant genospecies while the other genospecies (*B. burgdorferi*, *B. valaisiana*, and *B. spielmanii*) were found less frequently, as previously described (Tijsse-Klasen et al., [@B42]; Sprong et al., [@B38]). *B. garinii* and *B. afzelii* were detected with equal prevalences in N1 (2.2%) and variable prevalences in N2 (1.8 and 5.6%, respectively). The prevalence of *B. burgdorferi* s.s. was estimated at 1.4 and 0.5% in N1 and N2, respectively. *B. valaisiana* and *B. spielmanii* were identified in a single pool from the N2 site, but their prevalences were estimated at 0.5 and 0.3% in N1. In 2009, *B. lusitaniae* was described at one location (Sprong et al., [@B38]), but was not encountered in the present study. The relapsing fever spirochete, *B. miyamotoi*, previously identified in the Netherlands in a human case of meningoencephalitis (Hovius et al., [@B20]), occurred in both Dutch sites and was most prevalent in N2 (3.4%). In N1, *B. miyamotoi* showed the same prevalence as *B. garinii* and *B. afzelii* (2.2%). *Anaplasma phagocytophilum* and *Candidatu*s N. mikurensis were found in both sites with variable prevalences, both more abundant in N2 (2 and 7.9%, respectively). The estimated prevalence of *R. helvetica* was highly variable depending on the sites (11.9% in N1 and 4.5% in N2). These three bacteria are well recognized in Dutch ticks and have previously been reported in the Netherlands (Nijhof et al., [@B29]; Sprong et al., [@B40]; Tijsse-Klasen et al., [@B42]). Two parasitic species were found in Dutch ticks but were only observed in N2, *B. divergens* (0.2%) and *B. venatorum* (0.8%) with prevalence rates similar to previous reports (0.07 and 0.4% for *B. divergens* and 0.9 and 1.2% for *B. venatorum*) (Nijhof et al., [@B29]; Wielinga et al., [@B46]).

Discussion {#s4}
==========

In this study, we implemented a method using multiple primers/probe sets able to perform high-throughput detection of TBPs on an unprecedented scale. This large-scale investigation has (i) enabled the detection of rare pathogens such as *Bartonella henselae* and (ii) generated prevalence estimations for frequent, rare, or unexpected pathogens, thus creating a comprehensive overview of the epidemiological situation for 37 bacteria and parasites present in *I. ricinus*, in six European sites (two in France, Denmark, and the Netherlands).

Initial testing of the BioMark™ system showed that some pathogens could not be detected. Indeed, assessment was performed on positive DNA controls extracted from cultures, animal blood, ticks, or plasmids, therefore DNA quality and concentration were highly variable between samples. An initial step of pre-amplification was therefore added to specifically amplify targeted pathogen sequences. Regarding the three non-specific assays, two hypotheses can be made: either lack of specificity or potential co-infection of the DNA samples. As positive controls were isolated from pure bacterial cultures, only non-specific cross-reaction explains the lack of specificity. The set of primers and probe designed against *B. burgdorferi* s.s. cross-reacted with *B. garinii* and *B. valaisiana*. However, this cross-reaction did not occur for every field sample. Cross-reactions were also observed between *R. conorii* and *R. slovaca*. There was a difference of approximately 10 cycles between the CP values for the expected *Rickettsia* species and the cross-reacting species. It will be interesting to test both sets of primers and probe on DNA extracted from ticks uniquely infected with each of the *Rickettsia*. However, this issue is not likely to arise with field samples, as *R. slovaca* is transmitted by *Dermacentor marginatus* and *R. conorii* by *Rhipicephalus sanguineus*. In conclusion, the primers and probe sets for *B. burgdorferi* s.s., *R. conorii*, and *R. slovaca* need further optimization, so the current results obtained for these species should be interpreted with care. Several of the targeted pathogens cannot be cultured, or are rare and consequently unavailable from field samples, therefore plasmids containing target sequences were used as positive controls. For these pathogens and associated primers/probe sets, further evaluation of specificity is required. This tool was developed for epidemiologic rather than diagnostic purposes, therefore detection limits and sensitivity have not been experimentally determined. These experiments are somewhat difficult to implement and require a gold standard for each pathogen and consistent positive controls, which are not available for all TBPs.

Two sites per country were studied for the field investigation. The technique permitted the detection of 10 bacterial species; *B. burgdorferi* s.s., *B. garinii*, *B. afzelii*, *B. valaisiana*, *B. spielmanii*, *B. miyamotoi*, *A. phagocytophilum*, *Candidatus* N. mikurensis, *R. helvetica*, *B. henselae*, and two parasitic species; *B. divergens*, and *B. venatorum*, with variable prevalences according to the site of collection. Taken together, the estimated prevalences for all pathogens obtained on pools of 25 nymphs in this study are mostly consistent with European published data. For future studies, it will be fascinating to investigate smaller nymph pools to obtain more accurate estimations of TBP prevalences. The prevalence of *B. miyamotoi* is reported for the first time in Denmark at two sites and is quite similar between the three European countries in our study. *Borrelia miyamotoi* is transmitted by the same *Ixodes* species as the etiologic agents of European Lyme borreliosis, and has been detected in *Ixodes* ticks in Europe (Richter et al., [@B36]). Up until now no human cases have been reported in France or Denmark, but our data and the recent case of human infection described in the Netherlands (Hovius et al., [@B20]) suggest that surveillance needs to be improved. *Candidatus* N. mikurensis was detected in all three countries, with the highest prevalence in the Netherlands. Several human cases have been reported over the past decade in Europe (Maurer et al., [@B27]). However, clinical symptoms are not pathognomonic, suggesting the existence of unreported cases due to reduced awareness of symptoms by public health professionals (Jahfari et al., [@B21]). As this emerging human pathogen is widespread in Europe, it requires careful monitoring. *Rickettsia helvetica* was described as the most prevalent pathogen in all three countries. Even if its pathogenicity remains unclear, *R. helvetica* has been implicated in the development of fatal perimyocarditis (Sprong et al., [@B40]). Isolation of the bacterium from a patient is needed to definitely confirm *R. helvetica* as a human pathogen; however, *R. helvetica* already represents an excellent candidate for future emergence (Parola, [@B30]). Over the last few years, *I. ricinus* has been identified as a competent vector for *Bartonella henselae* (Cotte et al., [@B8]). Little data are available on its prevalence in ticks; and it has been estimated at between 11 and 40% in Europe (Dietrich et al., [@B13]). *Bartonella henselae* has never been reported in Danish ticks, but two variant types were detected in cats and mice (Engbaek and Lawson, [@B16]). Its presence in French ticks could be linked to the presence of wild cats in eastern France compared to the other countries. Babesiosis can be a variable but potentially severe disease, and is best known as an animal affliction. However, increasing numbers of human cases have refocused epidemiological attention on this emerging zoonosis (Hildebrandt et al., [@B19]). Our study demonstrates that these hemoparasites are widely present in European ticks, and were observed for the first time in Danish ticks. *Babesia microti* was not encountered in this study but has previously been detected in the Netherlands at a prevalence ranging from 0.1 to 9% (Wielinga et al., [@B46]; Tijsse-Klasen et al., [@B42]).

Interestingly, among the targeted pathogens, 15 bacterial species and 10 parasitic species were not detected in any country, leading us to conclude that they are not present in *I. ricinus* from those European sites. Indeed, these TBPs are either very rare (Parola and Raoult, [@B31]; Sprong et al., [@B39]) or have never been previously detected in the sampled regions, or are transmitted by other stage or other tick species (Parola and Raoult, [@B31]). *Francisella tularensis* and *Coxiella burnetii* are linked to important human and veterinary public health problems that require surveillance (Sprong et al., [@B39]; Carvalho et al., [@B5]); however, the role of ticks in the transmission of these pathogens is nonetheless debated. Their apparent absence across the three European countries in *I. ricinus* ticks suggests that the risk of acquiring tularemia or Q fever from questing ticks could be negligible.

This new screening approach based on microfluidic systems allowing multiple parallel real-time PCRs, is a powerful tool for TBP surveillance in Europe. This study demonstrates the technique\'s capacity for large-scale studies utilizing the unique ability to simultaneously analyze large numbers of samples and multiple target pathogens. As demonstrated for babesiosis, vector surveillance could be very useful for monitoring disease emergence (Diuk-Wasser et al., [@B15]). Compared to an array with fixed panels of probes, this new tool presents the major advantage that it can be easily adapted to new situations, as it is entirely possible to add or remove primers/probe sets in order to modify the panel of targeted pathogens and tick species. Further studies will indeed confirm if this approach heralds the necessary breakthrough in epidemiological surveillance of vector-borne pathogens, broadening the monitoring of human and animal diseases.

In conclusion, our study clearly demonstrates the utility of a fast tool that allows comprehensive testing of high numbers of TBPs in ticks, and can be easily customized to fit regional demands or to screen tick or host samples for new or emerging diseases.
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